Atovaquone is an oral anti-malarial. The patent on the API having expired, the innovator product (MALARONE) is now available in an oral suspension only. We have available an improved form of atovaquone, suitable for oral suspension, tablet or capsule finished dosage form. This product comes complete with a source of cGMP-inspected contract manufacturing and IP. To learn more, contact us.